Pcv65 - Expert Analysis on Cost Analysis of Management of Cardiovascular Disease Co-Morbidities

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.612
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Validation of Self-Reported Cardiovascular Disease and Associated Co- Morbidities in a Large Canadian Cohort of Early Inflammatory Arthritis

Rheumatology: Current Research
2017English

Predicting Co-Morbidities in Chemically Sensitive Individuals From Exhaled Breath Analysis

Interdisciplinary Toxicology
MutagenesisToxicologyHealthPharmacology
2012English

Parkinson Disease in a Patient With Multiple Co-Morbidities

Kansas Journal of Medicine
2019English

Co-Morbidities of Vertiginous Diseases

BMC Neurology
MedicineNeurology
2009English

Psy72 - Cost of Illness Analysis: Economic Burden in Direct Costs of Obesity-Related Co-Morbidities – Stroke, Myocardial Infarction, Type 2 Diabetes - In Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost Analysis of Mobility Management Entities of SINEMO

2011English

Co Morbidities in Chronic Obstructive Pulmonary Disease, Are We Aware

International Journal of Contemporary Medical Research [IJCMR]
2019English

SCAI/HFSA Clinical Expert Consensus Document on the Use of Invasive Hemodynamics for the Diagnosis and Management of Cardiovascular Disease

Catheterization and Cardiovascular Interventions
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2017English

Directions for Cost and Outcome Analysis of Starting Early Starting Smart: Summary of a Cost Expert Meeting

2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy